They Compared the Spice to the Drug. The Spice Won — Again. (Part 2)
Nature continues to put drugs to shame, yet why has no one heard of this research?
By Sayer Ji | October 6, 2026
Part 2 of our series. Part 1 can be found here. Ten more head-to-head clinical trials — pulled from the GreenMedInfo archive — in which ginger, St. John’s wort, garlic, saffron, valerian and a handful of other simple remedies matched or outperformed an antibiotic, Prozac, Aricept, Ritalin, a beta-blocker and a benzodiazepine. Each one links to the full research write-up.
In Part 1, honey beat a steroid fourteen-fold for chronic cough, turmeric stopped prediabetes in 100% of trial participants, and saffron ran even with Prozac. The response told us something: people are hungry for the studies nobody puts in a press release.
So for Part 2, we went back into the archive — 455,000 studies, hand-mapped since 2008 — and pulled ten more. This time we went after the drugs people take every day: the antibiotic for recurrent UTIs, the beta-blocker for blood pressure, the Alzheimer’s blockbuster, the stimulant given to millions of children, the benzodiazepine for sleep, and the antidepressants tens of millions of people take every morning.
Same rules as Part 1. Every study is a human trial. Every one is indexed in our database. Every one links to the long-form article or abstract so you can check the work yourself.
And the same caveat: this is research information, not medical advice. Some of these trials are large and well designed — the St. John’s wort meta-analysis covers 27 trials and 3,808 patients; the mindfulness trial ran in The Lancet. Others are smaller or single studies. I’ve given you the design and the numbers for each so you can weigh them. Never stop a prescribed medication without your practitioner.
1. Ginger vs. Dramamine — Motion Sickness

The trial: Randomized, double-blind comparison of a ginger preparation (Zintona) against dimenhydrinate — the active drug in Dramamine. European Phytotherapy, 1999.
The result: Everyone taking ginger had good results. Only 31% of those taking Dramamine did. And while the ginger group reported no side effects, 69% of the Dramamine group suffered them — the drowsiness, dry mouth and fog the drug is famous for.
It isn’t a one-off. On a Norwegian whale-watching voyage — seas that typically leave 80% of passengers sick — a 1994 double-blind study in the Journal of Travel Medicine found passengers given ginger did as well as those given any of six common seasickness medications. Over 80% felt fine.
→ Read the full article: Natural Remedies Found Superior to Drugs for Motion Sickness · Eight Unexpected Health Benefits of Ginger
2. D-Mannose vs. Nitrofurantoin — Recurrent Urinary Tract Infections

The trial: 308 women with recurrent UTIs, randomized after initial antibiotic treatment into three groups for six months: 2 grams of D-mannose powder (a simple sugar found in cranberries and other fruit) dissolved in water daily, 50 mg of the antibiotic nitrofurantoin daily, or no prevention at all. World Journal of Urology, 2014.
The result:
- No prevention: 60.8% had another infection.
- Nitrofurantoin (antibiotic): 20.4%.
- D-mannose (sugar powder): 14.6%.
A spoonful of a fruit sugar outperformed a daily antibiotic — without feeding antibiotic resistance, disrupting gut flora, or carrying the lung and liver warnings on nitrofurantoin’s label. Cranberry extract, separately, has been shown as effective as the antibiotic trimethoprim for preventing recurrent UTIs in older women.
→ Read the study: D-mannose powder significantly reduced the risk of recurrent UTI · The Amazing Healing Properties of 13 Common Fruits
3. St. John’s Wort vs. Prozac — Major Depression

The trial: Randomized, double-blind, 12 weeks: 900 mg/day of St. John’s wort extract versus 20 mg/day of fluoxetine (Prozac) in major depressive disorder. Journal of Clinical Psychopharmacology, 2005.
The result: St. John’s wort was significantly more effective than Prozac. End-point depression scores (HAMD-17) were 10.2 on the herb versus 13.3 on the drug.
The bigger picture: A 2017 meta-analysis in the Journal of Affective Disorders pooled 27 clinical trials and 3,808 patients comparing St. John’s wort against SSRIs. Response and remission rates were statistically equivalent. But patients on the herb were significantly less likely to drop out — the pooled odds of discontinuation were about 40% lower — which in antidepressant research is usually a proxy for side effects people can’t tolerate.
One honest note: St. John’s wort interacts with many medications, including birth control and blood thinners. It is gentle, not inert.
→ Read the study: St. John’s wort significantly more effective than fluoxetine · 27-trial meta-analysis · 23 Natural Alternatives for Depression
4. Garlic vs. Atenolol — High Blood Pressure

The trial: 210 patients with stage 1 hypertension split into seven groups of 30: five different daily doses of garlic tablets (300 mg up to 1,500 mg), the beta-blocker atenolol, or placebo. Blood pressure was measured at 0, 12 and 24 weeks. Pakistan Journal of Pharmaceutical Sciences, 2013.
The result: Every single garlic group — down to the lowest 300 mg dose — produced a significantly greater drop in both systolic and diastolic pressure than atenolol (p < 0.005). The effect grew with dose and with time.
Atenolol is one of the most prescribed blood-pressure drugs in the world, and it comes with fatigue, cold hands and feet, and sexual side effects. Garlic comes with garlic breath.
→ Read the full article: Garlic Compares Favorably to a Best-Selling Blood Pressure Drug · Study abstract
5. Ginkgo vs. Aricept — Alzheimer’s Disease

The trial: Randomized, double-blind, 22 weeks, 96 outpatients with Alzheimer’s. Three arms: 240 mg/day of standardized ginkgo extract (EGb 761), the $4-billion-a-year blockbuster donepezil (Aricept) at up to 10 mg/day, or both combined. Aging & Mental Health, 2009.
The result: Improvements in cognition and response rates were similar across all three groups — ginkgo did what Aricept did. But adverse events were lower with ginkgo than with the drug.
A separate 24-week, double-blind, placebo-controlled trial in the European Journal of Neurology (2006) reached the same conclusion: “no evidence of relevant differences in the efficacy” of ginkgo and donepezil. Donepezil, it’s worth knowing, is a cholinesterase inhibitor — the same mechanistic class as certain pesticides and nerve agents.
→ Read the full article: Declaring Chemical Warfare on the Brain — Alzheimer’s Drugs Are Neurotoxicants · Study summary
6. Saffron vs. Ritalin — ADHD in Children

The trial: Randomized, double-blind, six weeks: children with ADHD received 20–30 mg/day of saffron or 20–30 mg/day of methylphenidate (Ritalin), dosed by weight. Journal of Child and Adolescent Psychopharmacology, 2019.
The result: Both worked equally well. Saffron was as effective as Ritalin for ADHD symptoms.
A 2022 study in Nutrients followed children and adolescents aged 7–17 for three months on 30 mg of evening saffron versus extended-release methylphenidate. Efficacy on core symptoms and executive function was comparable, saffron tended to do better on hyperactivity — and parents in the saffron group reported their kids falling asleep faster, the opposite of the insomnia stimulants are known for.
Millions of children are on a Schedule II controlled substance. A spice deserves at least a seat at the table.
→ Read the full article: Ancient Spice Saffron Works as Well as Ritalin for ADHD
7. Melatonin vs. Amitriptyline — Migraine Prevention

The trial: Randomized, double-blind, placebo-controlled; 196 adults with 2–8 migraines a month. 3 mg of melatonin versus 25 mg of amitriptyline (a tricyclic antidepressant widely used for migraine prevention) versus placebo, for three months. Journal of Neurology, Neurosurgery & Psychiatry, 2016.
The result: Monthly migraine days fell by 2.7 on melatonin, 2.2 on amitriptyline and 1.1 on placebo. Melatonin was superior to the drug in the share of patients who cut their migraine frequency by more than half — and it was as well-tolerated as placebo.
The side-effect gap was visible on the scale: melatonin patients lost weight. Amitriptyline patients gained significantly. A molecule your own brain makes every night beat a drug that sedates, dries you out and adds pounds.
→ Read the full article: Melatonin Superior to Toxic Drug in Migraine Prevention Study
8. Hibiscus vs. Captopril — Hypertension

The trial: Phase II, randomized, double-blind, 134 patients with grade 1 hypertension, eight weeks. A standardized hibiscus and olive-leaf preparation at two doses versus 25 mg of the ACE-inhibitor captopril, twice daily. Phytotherapy Research, 2020.
The result: No significant difference in systolic or diastolic blood-pressure reduction between either herbal dose and captopril. The flowers did the drug’s job.
A meta-analysis of five studies and 390 participants found hibiscus lowered systolic pressure by nearly 8 mmHg and diastolic by 4 — in the range of a first-line medication. It’s the tart red tea sold in every Mexican market as agua de jamaica.
→ Read the full article: 6 Medicinal Properties of Hibiscus · Captopril trial abstract
9. Valerian vs. Oxazepam (a Benzodiazepine) — Insomnia

The trial: Randomized, double-blind, multicenter, 202 adults with insomnia, six weeks. 600 mg/day of valerian root extract versus 10 mg/day of oxazepam, a benzodiazepine in the same family as Valium and Xanax. European Journal of Medical Research, 2002.
The result: Valerian was at least as effective as the benzodiazepine for sleep quality. 82.8% of valerian patients rated their treatment “very good,” versus 73.4% on oxazepam. Adverse events: 28.4% on valerian, 36.0% on the drug.
Benzodiazepines carry an FDA boxed warning for dependence, withdrawal and abuse, and raise the risk of falls in older adults. Valerian root has been used for sleep since Hippocrates described it.
→ Read the full article: Top 6 Uses for Valerian · Study abstract
10. Mindfulness vs. Antidepressants — Preventing Depression Relapse

The trial: 424 patients with three or more past episodes of major depression, randomized and followed for two years. One group stayed on maintenance antidepressants. The other tapered off their medication while learning mindfulness-based cognitive therapy — eight group sessions plus home practice. The Lancet, 2015.
The result: At two years, relapse was 44% in the mindfulness group and 47% in the drug group. The researchers did not claim mindfulness was better — the difference wasn’t statistically significant — but that is exactly the point: people who came off their antidepressants and learned a practice did just as well as people who stayed on them, at no extra cost.
No pill, no weight gain, no sexual side effects, no withdrawal. Just training the mind you already have.
→ Read the full article: Mindfulness Therapy Better Than Antidepressants
Also in the Archive
- EPA omega-3 vs. Prozac: The omega-3 fatty acid EPA was as effective as fluoxetine for major depressive disorder (Australian & New Zealand Journal of Psychiatry, 2008).
- L-tryptophan vs. imipramine: The amino acid was as effective as the tricyclic antidepressant.
- Cranberry vs. trimethoprim: Cranberry extract matched the antibiotic for preventing recurrent UTIs in older women — without raising the risk of resistance or fungal infection.
→ Browse: 23 Natural Alternatives for Depression
Two Parts, Twenty Studies. Still Nobody’s Holding a Press Conference.
Across Parts 1 and 2, we’ve now shown you twenty peer-reviewed, head-to-head trials in which a food, an herb, a nutrient or a practice matched or beat a pharmaceutical — for cough, diabetes, depression, arthritis, flu, ulcers, motion sickness, UTIs, blood pressure, Alzheimer’s, ADHD, migraine and insomnia.
None of it is secret. All of it is sitting in the National Library of Medicine. It’s just buried under tens of millions of papers — and since 2021, PubMed no longer even lets you filter for complementary and alternative medicine.
That’s why GreenMedInfo exists: 455,000 studies, hand-mapped to the substances, conditions and mechanisms people actually search for, free to use. In 2020 they tried to take it away. It’s still here. It’s still yours.
Share this with one person who’s on one of these drugs. Then search the archive for your own condition — and bring what you find to your next appointment.
Help us grow our project to encompass the totality of the world’s literature supporting natural and integrative health approaches by becoming a member of GreenMedInfo here.
Share this:
Related
October 31, 2026 - Posted by aletho | Science and Pseudo-Science, Timeless or most popular | United States
Sorry, the comment form is closed at this time.
Featured Video
Thomas Fazi: NATO’s Hybrid Warfare – Deception & Permanent War
or go to
Aletho News Archives – Video-Images
Book Review
The Zeolite Book — First Edition, 2026, Paperback
The volcanic mineral medicine will not patent — for the toxic burden medicine will not name
Lies are Unbekoming – October 30, 2026
Zeolite is old. It is in Roman concrete that has held for two thousand years. It’s in the water filters of ancient cisterns. It’s in the stomachs of Pacific livestock whose keepers knew, somehow, that this grey crumbling rock made the animals healthier. It’s in Soviet clinical protocols from the 1960s. It’s in the standard emergency response to the Chernobyl explosion.
In 1986, after the Chernobyl reactor failure, the Soviet Union manufactured and distributed natural zeolite at industrial scale — for soil remediation, for livestock feed, for human consumption, for the cleanup itself. Karl Hecht, who had been director of the Institute for Experimental and Clinical Pathophysiology at the Charité of Humboldt University Berlin, spent the six decades after that building the clinical research base — on silicon’s role in human health, on zeolite’s clinical safety, on its applications in ageing. In 2018, Pavelić and colleagues published a comprehensive clinical safety review of natural clinoptilolite in Frontiers in Pharmacology. In 2019, Mastinu analysed its binding affinities. In the Western medical literature, these works sit largely uncited.
What has not been treated at book length, until now, is how a volcanic mineral with six decades of Soviet clinical work behind it, two major peer-reviewed Western reviews, and ongoing clinical use across the former Eastern Bloc, remains almost entirely absent from Western medical practice — and what the toxic burden it’s meant to address actually is.
The Zeolite Book gathers the Soviet clinical record, the Western peer-reviewed studies, three contemporary practitioner voices, and three serious counterviews into one honest treatment. That’s why the book runs to seven appendices. 288 pages, four parts, three practitioner voices, three counterviews, seven appendices. The honest treatment is the argument.
Blog Roll
-
Join 2,366 other subscribers
Visits Since December 2009
- 7,793,365 hits
Looking for something?
Archives
Calendar
Categories
Aletho News Civil Liberties Corruption Deception Economics Environmentalism Ethnic Cleansing, Racism, Zionism Fake News False Flag Terrorism Full Spectrum Dominance Illegal Occupation Mainstream Media, Warmongering Malthusian Ideology, Phony Scarcity Militarism Progressive Hypocrite Russophobia Science and Pseudo-Science Solidarity and Activism Subjugation - Torture Supremacism, Social Darwinism Timeless or most popular Video War Crimes Wars for IsraelTags
Afghanistan Africa AIPAC al-Qaeda Australia BBC Benjamin Netanyahu Brazil Canada CDC Central Intelligence Agency China CIA CNN Covid-19 COVID-19 Vaccine Donald Trump Egypt European Union Facebook FBI FDA France Gaza Germany Google Hamas Hebron Hezbollah Hillary Clinton Human rights Hungary India Iran Iraq ISIS Israel Israeli settlement Japan Jerusalem Joe Biden Korea Latin America Lebanon Libya Middle East National Security Agency NATO New York Times North Korea NSA Obama Pakistan Palestine Poland Qatar Russia Sanctions against Iran Saudi Arabia Syria The Guardian Turkiye Twitter UAE UK Ukraine United Nations United States USA Venezuela Washington Post West Bank WHO Yemen Zionism
Aletho News- Wrong, AP and NPR: Europe’s 50,000 Heat Deaths Are a Computer-Model Estimate, Not a Real Body Count
- Questioning Your Doctor Is Now Considered A Psychological Problem (Seriously)
- London tourism expo promotes Israeli agency linked to theft of Palestinian land
- Dockworkers launch global strike against Israeli and US military shipments
- Europe facing gas price shock – Gazprom chief
- Ukraine continues recruiting people with disabilities
- Weaponized Journalism: 2021 Sayer Ji Interview with NPR
- Beyond Netanyahu: what Israel’s election means for Palestinians
- Lithuania plans universal conscription
- Lies, Damn Lies, and Ukraine News
If Americans Knew- 1,300 will gather in Palo Alto on Nov. 1 for Z3 Conference on Zionism
- DAILY UPDATE: Latest essential news on Palestine, Israel, & region
- The Long Arm of AIPAC
- Genocidal intent behind Hebron assault, rights group says
- This week, Israel killed 8-year-old who survived bombing that wiped out her family
- DAILY UPDATE: Latest essential news on Palestine, Israel, & region
- Israeli soldier poses at damaged Lebanon church, sparking anger
- New Report. Manufacturing the Great Replacement: Is Israel behind one of the largest racist influence campaigns ever documented?
- ‘Arab voice doesn’t count’: Jewish Israeli blocs reject Palestinian support
- Whether Bibi Stays or Goes, the ‘Special Relationship’ Must End
No Tricks Zone- Germany’s Green Energy Transition Becoming Increasingly Expensive…Another 6 Trillion Euros!
- Sudden Stratospheric Warming, Powerful El Niño Combination May Lead To Extreme Europe Cold, Energy Crisis!
- Two New Studies Find Thwaites Glacier Melt Cannot Be Driven By Human Activity Or A Warming Ocean
- E-Cars Reduce CO2 Emissions By Only 41% Compared To Internal Combustion Engine Vehicles
- Predictions Made By Renowned Climate Professor Over Past Decades Have Been Proven To Be Poor
- New Study Suggests Large Regions Of The Pacific Ocean Have Been Cooling For The Last 80 Years
- Germany’s Green Energy Debacle: High Energy Costs Force Kahla Porzellan to Close After 182 Years!
- New Study: 50 Years Of The Most Aggressive ‘Net Zero’ Policies Can Only Affect The Global Climate By 0.03°C
- US September “Heat” Was No Record…Many Records Set Decades Ago
- Latest European Green Energy Debacle; Portugal’s Largest Flagship Solar Park Insolvent!
Contact:
atheonews (at) gmail.com
Disclaimer
This site is provided as a research and reference tool. Although we make every reasonable effort to ensure that the information and data provided at this site are useful, accurate, and current, we cannot guarantee that the information and data provided here will be error-free. By using this site, you assume all responsibility for and risk arising from your use of and reliance upon the contents of this site.
This site and the information available through it do not, and are not intended to constitute legal advice. Should you require legal advice, you should consult your own attorney.
Nothing within this site or linked to by this site constitutes investment advice or medical advice.
Materials accessible from or added to this site by third parties, such as comments posted, are strictly the responsibility of the third party who added such materials or made them accessible and we neither endorse nor undertake to control, monitor, edit or assume responsibility for any such third-party material.
The posting of stories, commentaries, reports, documents and links (embedded or otherwise) on this site does not in any way, shape or form, implied or otherwise, necessarily express or suggest endorsement or support of any of such posted material or parts therein.
The word “alleged” is deemed to occur before the word “fraud.” Since the rule of law still applies. To peasants, at least.
Fair Use
This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more info go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.
DMCA Contact
This is information for anyone that wishes to challenge our “fair use” of copyrighted material.
If you are a legal copyright holder or a designated agent for such and you believe that content residing on or accessible through our website infringes a copyright and falls outside the boundaries of “Fair Use”, please send a notice of infringement by contacting atheonews@gmail.com.
We will respond and take necessary action immediately.
If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question.
All 3rd party material posted on this website is copyright the respective owners / authors. Aletho News makes no claim of copyright on such material.
